Compare ASRT & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASRT | GEG |
|---|---|---|
| Founded | 1995 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 80.9M |
| IPO Year | 1997 | N/A |
| Metric | ASRT | GEG |
|---|---|---|
| Price | $11.38 | $2.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | 69.5K | ★ 75.6K |
| Earning Date | 11-10-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | ★ $137,354,000.00 | $23,112,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.66 |
| Revenue Growth | 9.22 | ★ 24.82 |
| 52 Week Low | $7.71 | $1.76 |
| 52 Week High | $15.15 | $3.51 |
| Indicator | ASRT | GEG |
|---|---|---|
| Relative Strength Index (RSI) | 87.55 | 43.13 |
| Support Level | $9.11 | $2.37 |
| Resistance Level | $10.39 | $2.55 |
| Average True Range (ATR) | 0.61 | 0.08 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 91.03 | 27.27 |
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.